$11.20
00.00%
Pre-Market: 6:23 AM EDT
15 minutes delayed
Comments
Loading...
Emergent BioSolutions
EBSNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Emergent BioSolutions (NYSE:EBS) Stock, Analyst Ratings, Price Targets, Forecasts
Emergent BioSolutions Inc has a consensus price target of $32.5 based on the ratings of 5 analysts. The high is $55 issued by Chardan Capital on November 9, 2022. The low is $8 issued by Benchmark on July 3, 2024. The 3 most-recent analyst ratings were released by Benchmark on July 3, 2024, July 2, 2024, and June 24, 2024, respectively. With an average price target of $8 between Benchmark, there's an implied -28.57% downside for Emergent BioSolutions Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Chardan Capital
Cowen & Co.
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Emergent BioSolutions
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | Buy Now | -28.57% | Benchmark | Robert Wasserman | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 07/02/2024 | Buy Now | -28.57% | Benchmark | Robert Wasserman | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | -28.57% | Benchmark | Robert Wasserman | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | -28.57% | Benchmark | Robert Wasserman | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2024 | Buy Now | -28.57% | Benchmark | Robert Wasserman | $5 → $8 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | -55.36% | Benchmark | Robert Wasserman | → $5 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | -55.36% | Benchmark | Robert Wasserman | → $5 | Upgrade | Hold → Buy | Get Alert |
| 11/20/2023 | Buy Now | — | JP Morgan | Jessica Fye | — | Reinstates | → Underweight | Get Alert |
| 08/29/2023 | Buy Now | — | Benchmark | Robert Wasserman | — | Downgrade | Buy → Hold | Get Alert |
| 05/31/2023 | Buy Now | 96.43% | Benchmark | Robert Wasserman | → $22 | Reiterates | Buy → Buy | Get Alert |
| 05/19/2023 | Buy Now | 96.43% | Benchmark | Robert Wasserman | → $22 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2023 | Buy Now | 96.43% | Benchmark | Robert Wasserman | → $22 | Upgrade | Hold → Buy | Get Alert |
| 03/17/2023 | Buy Now | -19.64% | JP Morgan | Jessica Fye | $23 → $9 | Downgrade | Neutral → Underweight | Get Alert |
| 11/10/2022 | Buy Now | — | Benchmark | Robert Wasserman | — | Downgrade | Buy → Hold | Get Alert |
| 11/09/2022 | Buy Now | 391.07% | Chardan Capital | Keay Nakae | $65 → $55 | Maintains | Buy | Get Alert |
| 09/12/2022 | Buy Now | 158.93% | Cowen & Co. | Boris Peaker | $30 → $29 | Maintains | Market Perform | Get Alert |
| 05/04/2022 | Buy Now | 239.29% | Wells Fargo | Jacob Hughes | $46 → $38 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | 480.36% | Chardan Capital | Keay Nakae | $75 → $65 | Maintains | Buy | Get Alert |
| 03/10/2022 | Buy Now | 257.14% | Wells Fargo | Jacob Hughes | $37 → $40 | Maintains | Equal-Weight | Get Alert |
| 11/10/2021 | Buy Now | 569.64% | Chardan Capital | Keay Nakae | — | Maintains | Buy | Get Alert |
| 11/08/2021 | Buy Now | — | Benchmark | Robert Wasserman | — | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE:EBS) was reported by Benchmark on July 3, 2024. The analyst firm set a price target for $8.00 expecting EBS to fall to within 12 months (a possible -28.57% downside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Emergent BioSolutions (EBS)?
The latest analyst rating for Emergent BioSolutions (NYSE:EBS) was provided by Benchmark, and Emergent BioSolutions reiterated their buy rating.
When was the last upgrade for Emergent BioSolutions (EBS)?
The last upgrade for Emergent BioSolutions Inc happened on March 7, 2024 when Benchmark raised their price target to $5. Benchmark previously had a hold for Emergent BioSolutions Inc.
When was the last downgrade for Emergent BioSolutions (EBS)?
The last downgrade for Emergent BioSolutions Inc happened on August 29, 2023 when Benchmark changed their price target from N/A to N/A for Emergent BioSolutions Inc.
When is the next analyst rating going to be posted or updated for Emergent BioSolutions (EBS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Emergent BioSolutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Emergent BioSolutions was filed on July 3, 2024 so you should expect the next rating to be made available sometime around July 3, 2025.
Is the Analyst Rating Emergent BioSolutions (EBS) correct?
While ratings are subjective and will change, the latest Emergent BioSolutions (EBS) rating was a reiterated with a price target of $8.00 to $8.00. The current price Emergent BioSolutions (EBS) is trading at is $11.20, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.